Award
Delivery Order #SPE2DR26FMEL4
Delivery Order for XOLAIR Syringes Awarded to DMS Pharmaceutical Group
Buyer
Defense Logistics Agency
Award Amount
$23,688.30
Ceiling
$23,688.30
Awarded
February 22, 2026
Period of Performance
Feb 22, 2026 – Mar 13, 2026
Identifier
SPE2DR26FMEL4
NAICS
424210
This award represents a delivery order under an existing indefinite delivery vehicle (IDV) pharmaceutical procurement contract managed by DMS Pharmaceutical Group Inc., a company specializing in providing healthcare and pharmaceutical products. The order procures XOLAIR 150 MG/ML syringes, a specific pharmaceutical product critical for treatment protocols. This procurement supports ongoing government healthcare programs by ensuring timely availability of this medication at the designated location in Park Ridge, Illinois. The contract underscores the agency's commitment to maintaining reliable access to essential pharmaceuticals, directly impacting patient care within public health facilities. The scope covers the procurement and delivery of the specified syringes within a short-term timeframe. This delivery order follows from the larger multi-year IDV contract previously awarded to DMS Pharmaceutical Group, facilitating efficient procurement through an established contract vehicle. The award was likely based on this existing competitive vehicle, ensuring streamlined and compliant acquisition processes. The performance period for this order is a concise multi-week interval, supporting immediate medical supply needs.
Description
4570956339!XOLAIR 150 MG/ML SYRINGEML